Alumis Inc. (ALMS)

Alumis Inc. (ALMS) is a healthcare company (biotechnology) based in the United States. The share price is $4.94, down 3.99% on the day, which values the company at $640.67M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$4.94−3.99% today
Market value
$640.67M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Alumis Inc. in more detail

ALMS trades at -1.7× next year's expected earnings, 88.5× sales.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold ALMS, including Julian and Felix Baker (0.3% of the portfolio).

Superinvestors holding ALMS

1 of the investors tracked here report a position in their latest 13F filing.

Alumis Inc. (ALMS): questions and answers

What is Alumis Inc.'s market cap?

Alumis Inc. is valued at $640.67M at a share price of $4.94.

Does ALMS pay a dividend?

Alumis Inc. does not currently pay a regular dividend.

Which famous investors own ALMS?

In their latest quarterly filings, Julian and Felix Baker (0.3% of the portfolio) hold ALMS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Alumis Inc. (ALMS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ALMS

Underlying data: Yahoo Finance; company filings with the SEC.